Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-11-23
1996-07-02
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142338, 5142342, 5142345, 514253, 514254, 514255, 514925, A61K 3154, A61K 31535, A61K 31495
Patent
active
055322344
ABSTRACT:
The present invention relates to the use of 1-{4-[4-aryl(or heteroaryl)-1-piperazinyl]butyl}-1H-azole derivatives and of their physiologically acceptable salts for the manufacture of medicaments intended for the treatment of disorders associated with gastric secretion.
REFERENCES:
The Journal of Pharmacology and Experimental Therapeutics, vol. 262, No. 1, 1992, pp. 90-98-Costall et al., "Profile Of Action Of A Novel 5-Hydroxytryptamine 1A receptor Ligand E-4424 To Inhibit Aversive Behavior In The Mouse, Rat and Marmoset".
Frigola-Constansa Jordi
Merce-Vidal Ramon
Laboratories Del Dr. Esteve, S.A.
Weddington Kevin E.
LandOfFree
Use of 1-[4-[4-aryl (or heteroaryl)-1-piperazinyl]-butyl)-1H-azo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 1-[4-[4-aryl (or heteroaryl)-1-piperazinyl]-butyl)-1H-azo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 1-[4-[4-aryl (or heteroaryl)-1-piperazinyl]-butyl)-1H-azo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1506538